Todd Harrison Discusses Biopharmaceutical Investments

Bloomberg Opinion columnist Barry Ritholtz interviews Todd Harrison, a founding partner and chief investment officer at the hedge fund CB1 Capital, which focuses on cannabinoid-based solutions and biopharmaceutical applications and therapies. Prior to his work with CB1 Capital, Harrison spent almost three decades on Wall Street managing risk and researching financial market strategies. He was also thefounder and CEO of Minyanville Media Inc., an Emmy-winning financial media company covering global markets in real time. See omnystudio.com/listener for privacy information.